D. Chung

Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active treatment, but maintenance of pre-existing antibody levels against endemic viruses.

A. Vlasova, I. Carmody, E. Oltz, 2022, medRxiv.

Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma,

Jeffrey A Jones, J. Byrd, R. Baiocchi, 2010 .

Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver‐Distributed Farnesoid X‐Receptor Agonist TERN‐101 in Healthy Volunteers

Christopher Jones, M. Fenaux, M. Charlton, 2021, Clinical pharmacology in drug development.

Peptides Derived from the Complementarity-determining Regions of Anti-Mac-1 Antibodies Block Intercellular Adhesion Molecule-1 Interaction with Mac-1*

J. Scardina, A. Guzzetta, Andrew Lam, 1998, The Journal of Biological Chemistry.

Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion

E. Weeber, A. Anderson, E. Berg, 2020, Autism research : official journal of the International Society for Autism Research.